Retrieved from DailyMed: Wittmer Rejuvenation Clinic
Anti-inflammatory approaches, such as the IL-1 inhibitor canakinumab in the CANTOS trial, have also been used to reduce cardiovascular events (117)
Still, in 2018, former FDA commissioner Scott Gottlieb testified before Congress that the agency had found "problematic conditions" during most of its 500 inspections of compounding pharmacies from late 2013 to 2017
The risk may be greater in people who have had these thoughts or actions in the past
References BERG, J.M., TYMOCZKO, J.L
The findings highlight a challenge as peptides become more mainstream: understanding what level of evidence exists for a given peptide and how its being sourced, prescribed, and monitored